Home

Strides Pharma Science Limited

NSE: STAR

₹993.00
+3.71%
EOD snapshot

About Strides Pharma Science Limited

Strides Pharma Science Limited, a pharmaceutical company, engages in the development, manufacturing, and marketing of pharmaceutical products in North America, Australia, Africa, Europe, India, the rest of Asia, and internationally. The company offers generic finished dosage formulations in a range of dosages, such as tablets, hard capsules, sachets, liquids, nasal sprays, topical formulations, and controlled substances; and therapeutic products, including antivirals, antibiotics, NSAIDs, and allergy treatment. It also provides branded generics, prescription medicines, and over-the-counter products for infectious diseases, pain management, cardiology, and wellness; and prescription generics for anti-infectives, CNS, cardiovascular, gastroenterology, pain management, and specialty products. The company was formerly known as Strides Shasun Limited and changed its name to Strides Pharma Science Limited in July 2018. Strides Pharma Science Limited was incorporated in 1990 and is headquartered in Bengaluru, India.

Healthcare · Drug Manufacturers - Specialty & Generic

Full scanner analysis & price chartMembers

Results

No scheduled results found for STAR.

Historical quarterly results aren't available in the current data feed.

Corporate Actions

No recent corporate actions for STAR.

Latest News · Strides Pharma Science Limited

Loading news…

More in Healthcare

All companies, by sector

Company overview assembled from NSE results / corporate-action feeds and market news. Not investment advice.